What Are Analysts Suggestions On Corcept Therapeutics Incorporated (CORT)


Corcept Therapeutics Incorporated (CORT) will report its next earnings on Aug 01 AMC. The company reported the earnings of $0.1/Share in the last quarter where the estimated EPS by analysts was $0.07/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 42.9%.

Many analysts are providing their Estimated Earnings analysis for Corcept Therapeutics Incorporated and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $0.13/share. These analysts have also projected a Low Estimate of $0.12/share and a High Estimate of $0.17/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Corcept Therapeutics Incorporated as 41.64 Million. According to these analysts, the Low Revenue Estimate for Corcept Therapeutics Incorporated is 40.3 Million and the High Revenue Estimate is 45.76 Million. The company had Year Ago Sales of 21.73 Million.

Some buy side analysts are also providing their Analysis on Corcept Therapeutics Incorporated, where 2 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 1 reported it as Underperform and 1 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Corcept Therapeutics Incorporated might touch $24 high while the Average Price Target and Low price Target is $17.75 and $6 respectively.

The Relative Volume of the company is 1.81 and Average Volume (3 months) is 1.11 million. The company’s P/E (price to earnings) ratio is 88.95 and Forward P/E ratio of 25.41.

The company shows its Return on Assets (ROA) value of 33%. The Return on Equity (ROE) value stands at 51.4%. While it’s Return on Investment (ROI) value is 18.1%.

While looking at the Stock’s Performance, Corcept Therapeutics Incorporated currently shows a Weekly Performance of 5.89%, where Monthly Performance is 30.04%, Quarterly performance is 62.17%, 6 Months performance is 65.18% and yearly performance percentage is 224.64%. Year to Date performance value (YTD perf) value is 145.04%. The Stock currently has a Weekly Volatility of 4.36% and Monthly Volatility of 4.65%.